Penny Stocks Post's  Instablog

Penny Stocks Post
Send Message
I am the blogger at I will write daily blogs on the most active and need to know about penny stocks in the market. Signup for the free newsletter at our site, and read the daily columns on the website you will not be disappointed. My content will be second to none.
My company:
Penny Stocks Post
  • PFSCF Announces HUGE NEWS! 2 comments
    Feb 9, 2014 9:00 PM | about stocks: PFSCF

    ProMetic Life Sciences

    We have another stock that we are encouraging you to put on your radar, PFSCF!

    ABOUT PFSCF: ProMetic Life Sciences Inc. ( is a long established biopharmaceutical company with globally recognized expertise in bioseparations, plasma-derived therapeutics and small-molecule drug development. ProMetic offers its state of the art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop best-in-class therapeutics and orphan drugs. ProMetic is also active in developing its own novel small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, cancer and autoimmune diseases/inflammation. Headquartered in Laval (Canada), ProMetic has R&D facilities in the UK, the U.S. and Canada, manufacturing facilities in the UK and business development activities in the U.S., Europe and Asia.

    PFSCF announced HUGE news that could send the PPS THROUGH THE ROOF!

    PFSCF is trading for right around $1.20 and they entered into a 16 MILLION dollar deal!

    This news already tripled the average volume!

    Check out the news:

    announced today that its UK based subsidiary, ProMetic BioSciences Ltd. ("PBL"), has entered into a new agreement with a leading vaccines company, for the development of an affinity adsorbent and associated purification process for the production of a novel vaccine product.

    Under this new Agreement, PBL will use its ligand design and screening capabilities to identify Mimetic™ affinity ligand(s) with the ability to capture and purify the novel vaccine product. Once suitable ligands have been identified, they will be further developed to provide an affinity resin product and associated process conditions to be used in commercial vaccine manufacturing by PBL's client.

    The Agreement is structured to provide ProMetic with potential initial service revenues of up to $1.6 million over the next twelve months assuming successful completion of ongoing milestones, with work commencing immediately. This agreement is also anticipated to lead to a subsequent long-term agreement for the manufacture and supply of the affinity resin for use in scale-up and commercial production of the vaccine product.

    "ProMetic's state-of-the-art affinity technology has demonstrated capability to develop affinity purification solutions for almost any target biomolecule including genetically engineered viral surface proteins which form the basis of a growing number of vaccine products" said Dr. Steve Burton, PBL's Chief Executive Officer. "Vaccines are produced in large quantities and must be highly purified to avoid any unwanted side-effects which are generally considered to be unacceptable in the case of a therapeutic product given to healthy individuals to protect against viral infection" added Dr Burton.

    "We are pleased to be adding a new client for which we will have the opportunity to demonstrate the outstanding performance of our purification technologies", mentioned Mr. Pierre Laurin, President and Chief Executive Officer of ProMetic. "We believe our bioseparation solutions to be especially well suited for the purification of products manufactured in large quantities given the superior purification yield and economic advantages they provide" Laurin said.

    The chart is even looking very nice!

    Make sure you sign up for our FREE Newsletter to receive the FULL report on PFSCF!

    Stocks: PFSCF
Back To Penny Stocks Post's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (2)
Track new comments
  • bigbuckric
    , contributor
    Comments (88) | Send Message
    This is going to the moon skyhigh123
    10 Feb 2014, 02:47 PM Reply Like
  • bigbuckric
    , contributor
    Comments (88) | Send Message
    PFSCF is trading for right around $1.20 and they entered into a 16 MILLION dollar deal!


    SHOULD BE 1.6 MILLION not 16 (typo by penny stocks posts )skyhigh123
    10 Feb 2014, 04:30 PM Reply Like
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.